These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2863463)

  • 1. Importance of highly sensitive serological tests for cytomegalovirus in bone marrow transplant patients.
    Osterwalder B; Reusser P; Gratwohl A; Gratama JW; The TH; Speck B
    Lancet; 1985 Aug; 2(8452):442. PubMed ID: 2863463
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.
    Emanuel D
    Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Two cases of acute non-lymphoblastic leukemia treated with allogeneic bone marrow transplantation].
    Yamada H; Yamaguchi H; Furukawa K; Yoshida K; Kodera Y; Shiku H; Ono R; Yamada K; Yamamoto M; Fukatsu T; Saka Y; Hirabayashi N; Satake T
    Rinsho Ketsueki; 1982 Apr; 23(4):541-50. PubMed ID: 6290710
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.
    Meyers JD
    Birth Defects Orig Artic Ser; 1984; 20(1):101-17. PubMed ID: 6329356
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoprophylaxis of infections with human cytomegalovirus in BMT patients.
    Mach M; Landini MP
    Bone Marrow Transplant; 1993; 11 Suppl 1():95-6. PubMed ID: 8383558
    [No Abstract]   [Full Text] [Related]  

  • 7. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
    [No Abstract]   [Full Text] [Related]  

  • 8. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
    Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
    J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
    Pollard RB; Merigan TC
    Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with transfusion of CMV tested blood preparations after bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen DW; Quabeck K; Thraenhart O
    Beitr Infusionsther; 1990; 26():190-3. PubMed ID: 1703827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus seroconversion in patients receiving intensive induction therapy prior to allogeneic bone marrow transplantation.
    Kelsey SM; Newland AC
    Bone Marrow Transplant; 1989 Sep; 4(5):543-6. PubMed ID: 2551435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia.
    Jacobsen N; Keiding N; Ryder L; Ringdén O; Lönnqvist B; Gahrton G; Rajantie J; Siimes M; Volin L; Ruutu T
    Lancet; 1987 Feb; 1(8530):456-7. PubMed ID: 2880255
    [No Abstract]   [Full Text] [Related]  

  • 14. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
    Schmidt GM; Kovacs A; Zaia JA; Horak DA; Blume KG; Nademanee AP; O'Donnell MR; Snyder DS; Forman SJ
    Transplantation; 1988 Dec; 46(6):905-7. PubMed ID: 2849818
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
    Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
    N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant.
    Bowden RA; Fisher LD; Rogers K; Cays M; Meyers JD
    J Infect Dis; 1991 Sep; 164(3):483-7. PubMed ID: 1651360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus immune plasma in bone marrow transplant recipients.
    Winston DJ; Pollard RB; Ho WG; Gallagher JG; Rasmussen LE; Huang SN; Lin CH; Gossett TG; Merigan TC; Gale RP
    Ann Intern Med; 1982 Jul; 97(1):11-8. PubMed ID: 6283982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
    Schmeiser T; Heit W
    Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.